PPMonitor checks laboratory air quality
Enables effective and flexible management of indoor air quality
The PPMonitor, from the Caernarfon, Wales firm, can continuously detect, measure and record temperature, humidity, formaldehyde, nitrogen dioxide, carbon monoxide, carbon dioxide, sulphur dioxide, ozone, ammonia and TVOCs.
The device incorporates a variety of advanced gas sensor technologies to monitor the target gases including NDIR, PID and electrochemical sensors.
The wireless units communicate via the Zigbee wireless mesh network, which can be extended by adding repeater nodes or additional PPMonitor or Mini PPMonitor units. Each unit can be configured with unique sensor specifications if required, allowing complete monitoring of the cleanroom air environment.
PPMonitor Units can be wirelessly connected to a Building Management System, in which BMS software allows the entire wireless system to be managed from a single PC. The BMS can activate and control air conditioning and ventilation systems; it can also turn on/off heating and trigger building alarms, if required.
All recorded data is stored automatically with dedicated software, which enables the data to be viewed graphically and produces reports and statistical data. Analysis of the recorded data over time allows for more efficient management of resources and energy.
You may also like
Regulatory
FDA grants Breakthrough Therapy designation to BeOne Medicines' sonrotoclax
Read moreThe designation comes after positive early results of a Phase I/II study in patients with relapsed or refractory mantle cell lymphoma, with BeOne aiming to participate in Project Orbis programme to advance global access
Trending Articles
You may also like
Regulatory
FDA grants Breakthrough Therapy designation to BeOne Medicines' sonrotoclax
The designation comes after positive early results of a Phase I/II study in patients with relapsed or refractory mantle cell lymphoma, with BeOne aiming to participate in Project Orbis programme to advance global access
Regulatory
Zelluna receives positive MHRA feedback and advances UK clinical plans for ZI-MA4-1
Zelluna has secured alignment with the UK’s MHRA on the clinical and regulatory pathway for its TCR-NK therapy ZI-MA4-1, paving the way for a CTA submission by the end of 2025 and first-in-human trials at The Christie and The Royal Marsden in 2026
Regulatory
Analytical vigilance saves lives
The EDQM has updated Ph. Eur. monographs to detect ethylene glycol and diethylene glycol. Butterworth Laboratories supports compliance through validated chromatographic testing, impurity screening, and documentation—helping pharmaceutical companies ensure product safety and protect patient lives